Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its relationship with multidrug resistance by Babapour, E. et al.
HOSTED BY Contents lists available at ScienceDirect
Asian Pac J Trop Biomed 2016; 6(6): 528–533528Asian Paciﬁc Journal of Tropical Biomedicine
journal homepage: www.elsevier.com/locate/apjtbOriginal article http://dx.doi.org/10.1016/j.apjtb.2016.04.006*Corresponding author: Nour Amirmozafari, Professor of Microbiology, Iran
University of Medical Sciences, School of Medicine, Microbiology Department,
Tehran, Iran.
Tel: +98 9123877988
Fax: +98 2188058649
E-mail: amirmozafari@yahoo.com
The study was performed according to the Helsinki Declaration of 1975, as
revised in 1983. All patients gave written informed consent before recruitment.
Foundation Project: Supported by an educational grant for doctoral thesis from
Islamic Azad University of Karaj (grant number: 11530554922001).
Peer review under responsibility of Hainan Medical University. The journal
implements double-blind peer review practiced by specially invited international
editorial board members.
2221-1691/Copyright © 2016 Hainan Medical University. Production and hosting by Elsevier B.V. This is an open access
creativecommons.org/licenses/by-nc-nd/4.0/).Biofilm formation in clinical isolates of nosocomial Acinetobacter baumannii and its
relationship with multidrug resistanceEbrahim Babapour1, Azam Haddadi1, Reza Mirnejad2, Seyed-Abdolhamid Angaji3, Nour Amirmozafari4*1Department of Microbiology, Karaj Branch, Islamic Azad University, Karaj, Iran
2Medical Bacteriology, Molecular Biology Research Center, Baqiyatallah University of Medical Sciences, Tehran, Iran
3Department of Cell and Molecular Biology, Faculty of Biological Sciences, Kharazmi University, Tehran, Iran
4Iran University of Medical Sciences, School of Medicine, Microbiology Department, Tehran, IranARTICLE INFO
Article history:
Received 28 Dec 2015
Received in revised form 5 Jan, 2nd
revised form 28 Jan 2016
Accepted 1 Feb 2016
Available online 20 Apr 2016
Keywords:
Acinetobacter baumannii
Bioﬁlm
Multidrug resistance
Nosocomial infectionsABSTRACT
Objective: To check bioﬁlm formation by Acinetobacter baumannii (A. baumannii)
clinical isolates and show their susceptibility to different antibiotics and investigate a
possible link between establishment of bioﬁlm and multidrug resistance.
Methods: This study was performed on clinical samples collected from patients with
nosocomial infections in three hospitals of Tehran. Samples were initially screened by
culture and biochemical tests for the presence of different species of Acinetobacter. Iden-
tiﬁcations were further conﬁrmed by PCR assays. Their susceptibilities to 11 antibiotics of
different classes were determined by disc diffusion method according to Clinical and
Laboratory Standards Institute guidelines. The ability to produce bioﬁlm was investigated
using methods: culture on Congo red agar, microtiter plate, and test tube method.
Results: From the overall clinical samples, 156 specimens were conﬁrmed to contain
A. baumannii. The bacteria were highly resistant to most antibiotics except polymyxin B.
Of these isolates, 10.26% were able to produce bioﬁlms as shown on Congo red agar.
However, the percentage of bacteria with positive bioﬁlm in test tube, standard microtiter
plate, and modiﬁed microtiter plate assays were 48.72%, 66.66%, and 73.72%, respec-
tively. At least 92% of the bioﬁlm forming isolates were multidrug resistant.
Conclusions: Since most of the multidrug resistant strains produce bioﬁlm, it seems
necessary to provide continuous monitoring and determination of antibiotic susceptibility
of clinical A. baumannii. This would help to select the most appropriate antibiotic for
treatment.1. Introduction
Acinetobacter baumannii (A. baumannii) is responsible for
the majority of nosocomial infections. The bacterium showswide range antibiotics resistance towards cephalosporins, peni-
cillins, carbapenems, ﬂuoroquinolones and aminoglycosides. It
is often isolated from respiratory tract through which it infects
installed catheters. This will eventually lead to fever, pneu-
monia, bacteremia, and meningitis [1–3]. Among A. baumannii
different virulence factors, the most important one is the
ability to produce bioﬁlms and their survival in hospital
environment which is related to their high degree of antibiotic
resistance [4–7]. Bioﬁlms are complex mixtures of microbes
which are predominantly attached to hard surfaces. They are
often enclosed by thick polysaccharide layer which makes
them resistant to antibiotics and thus very hard to eliminate
[8,9]. The ability to produce bioﬁlms causes bacteria to endure
relatively hard conditions. Bacteria binding to artiﬁcial
surfaces in hospitals induce long-term durability and tolerancearticle under the CC BY-NC-ND license (http://
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These features make eradication of bioﬁlm-associated bacteria
almost impossible from hospital environments [1,7,10,11]. On the
other hand, sensitivity to different antibiotics as well as
microbial metabolism due to bioﬁlm formation will be
reduced. This is attributable to lack of food in the bioﬁlm
depth. Slower metabolism and antibiotic resistance lead to
bacterial dissemination which can create a quick critical
situation [12]. This may increase the incidence of nosocomial
infections caused by bacteria, especially in patients in
intensive care and those in burn and surgery units [4–6]. This
study focused on determination of bioﬁlm formation in clinical
isolates of A. baumannii, elucidation of their sensitivity to
different antibiotics, and presenting any possible link between
the ability to form bioﬁlm and multidrug resistance (MDR)
status.
2. Materials and methods
2.1. Collection, separation and identiﬁcation of isolates
In this cross-sectional study, a total of 650 clinical samples
were taken from patients who spent at least one week of their
hospitalization duration in Imam Khomeini, Milad and Motahari
Hospitals (Tehran, Iran) during the years 2013–2014 (second
half of 2013 and ﬁrst six months of 2014). The collected spec-
imens included blood, urine, sputum, catheter, bronchial, spinal
ﬂuid [(cerebrospinal ﬂuid) CSF], bronchoalveolar lavage, exu-
dates and burned skin. Specimens were placed in brain-heart
infusion broth medium and then transferred to microbiology
lab for culture. Isolates were initially identiﬁed using standard
laboratory methods including growth on blood agar (non-he-
molytic), MacConkey agar medium (Merck, Germany) at 37 C
showing a pink to light purple appearance, Gram stain (Gram
negative coccobacilli), catalase test (positive), oxidase test
(negative), oxidative-fermentative test for glucose (producing
acid from glucose in oxidative state), sulﬁde indole motility,
methyl red-Voges-Proskauer, citrate utilization, urease test, tri-
ple sugar iron (non-fermentative or alkaline/alkaline), and
growth at 44 C on nutrient agar (Merck, Germany).
2.2. Molecular identiﬁcation of isolates by PCR
Presence of blaOXA-51-like gene was veriﬁed using PCR
according to Turton's experiment [13]. Genomic DNA was
extracted by boiling method. All DNA isolates were subjected
to PCR for identiﬁcation of blaOXA-51 gene. Negative
samples were tested for second time with the PCR. The
primers were F-TAATGCTTTGATCGGCCTTG- and R-
TGGATTGCACTTCATCTTGG- (353 bp) [14]. A single
reaction mixture contained: 1 mL DNA (0.8 mmol/L), 12.5 mL
ready 2× PCR Master Mix (composition of 1× solution:
0.5 mol/L Tris–HCl, 1.5 mmol/L MgCl2, 0.2 mmol/L dATP,
0.2 mmol/L dCTP, 0.2 mnol/L dGTP and 0.2 mmol/L dTTP
and 0.04 IU/mL Taq) (SinaClon BioScience Co., Iran), 1 mL
of 10 pmol/L of each primer and 9.5 mL of sterile ultrapure
water, with ﬁnal volume of 25 mL. The PCR protocol included
30 cycles of ampliﬁcation under the following condition:
initial denaturation at 94 C (5 min), denaturation at 94 C
(45 s), annealing at 58 C (60 s), extension at 72 C (60 s),
and ﬁnal extension at 72 C (5 min) [14]. PCR products wereelectrophoresed on 1.2% agarose gel, followed by staining
with safe DNA stain and illumination under UV light. Fifty bp
DNA ladder was used for size determination.
2.3. Susceptibility testing of bacterial isolates to
antibiotics
Antibiotic susceptibilities towards eleven clinically relevant
antibiotics were determined by Kirby–Bauer disc diffusion
method based on Clinical and Laboratory Standards Institute
guidelines using antibiotic discs supplied by Rosco Diagnostica
(Denmark). The antibiotic discs were as follows: piperacilin
(PIP, 100 mg), ceftriaxone (CRO, 30 mg), cefepime (FEP,
30 mg), imipenem (IPM, 10 mg), polymyxin B (PB, 300 mg),
gentamicin (GM, 10 mg), tetracycline (TE, 30 mg), ciproﬂoxacin
(5 mg), sulfamethoxazole-trimethoprim (SXT, 75 mg), ticarcilin
(TIC, 75 mg), and ticarcillin/clavulanic acid (TCC, 75/10 mg).
Inoculums of the A. baumannii isolates (106 CFU/mL) were
swabbed onto Muller-Hinton agar (Merck, Germany) plates and
antibiotic discs were then placed on the inoculated plates. They
were incubated at 37 C for 24 h after which the growth inhi-
bition zones around each disc were measured. Pseudomonas
aeruginosa ATCC 27853 and Escherichia coli ATCC 25922
were used as reference strains for quality control [15].
2.4. Congo red agar (CRA) method (qualitative bioﬁlm
production assay)
A simple qualitative assay for detection of bioﬁlm, using
CRA medium, was described by Freeman et al. [10]. Following
inoculation, the agar plates were incubated at 37 C for 24–48 h.
Appearance of black colonies with a dry crystalline consistency
could be considered as strong evidence for ability to form
bioﬁlm. Each experiment was conducted in three repeats.
2.5. Tube method (quantitative bioﬁlm production
assay)
A quantitative assay for bioﬁlm detection has been proposed
by Christensen et al. [16]. A heavy inoculation of bacteria was
made in a test tube containing 3 mL of tryptic soy broth
(TSB). The inoculated tubes were placed in 37 C incubator
for 48 h. After decanting, the bacterial cell pellets were
washed with phosphate buffer saline (pH 7.3) and allowed to
dry. Tubes were stained with safranin (1%) for 7 min and then
washed with distilled water for 5 min. Presence of an attached
ﬁlm of stained material on the tube inner surface was
indicative of bioﬁlm formation. Sterile TSB tubes were used
as negative control.
2.6. Tissue culture plate method (quantitative bioﬁlm
production assay)
This assay which was proposed by Christensen et al. is
generally considered to be the gold-standard technique for bio-
ﬁlm detection [17]. Bacterial cells were grown overnight at 37 C
in 10 mL TSB (Merck). Each well of a 96-well ﬂat-bottomed
polystyrene tissue culture plate (3 wells for each strain) was
ﬁlled with 20 mL of the overnight culture (equivalent to 0.5
McFarland standard). Sterile TSB medium (180 mL) was added
into each well. The bioﬁlm producing reference strain of
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inoculated with sterile broth were used as negative control. The
plates were covered with a lid and incubated aerobically for
24 h at 37 C. After incubation, the content of each well was
removed and the wells were carefully washed, three times, with
0.2 mL of phosphate buffer saline (pH 7.2) in order to remove
free ﬂoating bacteria.
Adherent bacteria were ﬁxed with 200 mL of 99% methanol
per well for 15 min. The plates were decanted and allowed to
dry. Then, plates were stained for 7 min with 0.2 mL of 2%
Hucker crystal violet. Excess stain was rinsed off by washing
with tap water. After the plates were air dried, the dye bound to
the adherent cells was resolublized with 160 mL of 33% (v/v)
glacial acetic acid per well. The optical density (OD) of each
well was measured at 630 nm using ELISA reader (Stat Fax
2100).
The absorbance values were read for two times: ﬁrstly prior
to addition of glacial acetic acid, and secondly after addition of
glacial acetic acid. According to the absorbance values, the
adherence capability of each bacterial cell was classiﬁed into the
following four categories: none (−), weak (+), moderate (++),
and strong (+++) adherent cells. The cut-off absorbance value
(ODc) was considered as three standard deviations above the
mean OD of the negative control. Tests were performed for three
times and results were averaged [4–6]. The following
classiﬁcations were used (Table 1):Table 1
Adherence classiﬁcation based on microtiter plate method.
Mean OD value Adherence Bioﬁlm formation
OD  ODc None None
ODc < OD  2 ODc Weak Weak
2 ODc < OD  4 ODc Moderate Moderate
4 ODc < OD Strong High
Figure 1. PCR products of the blaOXA-51-like gene in A. baumannii.
The ﬁrst well: 50 bp ladder; second to eighth wells are related to the clinical
isolates; the last well is for the control strain, A. baumannii ATCC 19606.
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Figure 2. The antibiotic susceptibility patterns of the A. baumannii iso-
lates.
CP: Ciproﬂoxacin.2.7. Statistical analysis
One way ANOVA was applied using SPSS 16 in order to
compare differences among tube test method, microtiter plate
under standard and modiﬁed conditions. The experiments were
performed in triplicate. P values of  0.05 were considered as
signiﬁcant.
3. Results
Of the 650 clinical specimens tested, 195 Acinetobacter spp.
were isolated. Of these, 156 were A. baumannii, 27 samples
were Acinetobacter lwofﬁi (A. lwofﬁi) and 12 samples belonged
to other species. Among the 156 A. baumannii isolates, 83 were
obtained from hospitalized women and the rest were from men.
The patient's age groups were between 2 and 75 years old. All
isolates were ﬁnally recognized by both biochemical tests as
well as PCR for blaOXA-51 gene (Figure 1). A. baumannii
isolates were recovered from tracheal aspirate (23%), sputum
(21%), urine (17%), burned skin (17%), wound (10%), blood
(5%), sterile body ﬂuids (5%) and other samples (2%). The
lowest number of isolate 2 was from bone and 3 isolates were
recovered from CSF. Disc diffusion tests indicated that 95.51%
of the isolates were resistant to PIP (100), 94.87% to CRO (30),94.23% to FEP (30), 91.03% to IPM (10), 83.33% to GM (10),
72.44% to TE (30), 89.10% to SXT (75), 93.59% to TIC (75),
and 91.03% to TCC (75/10). There was a high degree of sus-
ceptibility to PB (300) (Figure 2). The results showed that
92.95% of the A. baumannii isolates examined in this study were
MDR and 86.53% were extensively drug-resistant; however,
none of them was pan-drug resistant. Almost 60% of the isolates
were resistant to 10 of the 11 antibiotics tested and only 5 iso-
lates were sensitive to all antibiotics.Sixteen of the total 156 isolates that were cultured on the
CRA medium produced black colony pigmentation which was
considered to be a rough indication of the ability to produce
bioﬁlm (Figure 3). However, in the more reliable tube method,
25 isolates were non-bioﬁlm producers, 55 were weak bioﬁlm
formers, 51 were moderate bioﬁlmers, and 25 isolates produced
bioﬁlms with high power (Figure 4). The results of bioﬁlm
formation in the standard microtiter plate method showed that
three isolates were not able to produce bioﬁlm, 49 isolates
formed bioﬁlm weakly, 91 isolates created bioﬁlm moderately,
and 13 isolates were strong bioﬁlm producers. In the modiﬁed
microtiter plate assay, one isolate was non-bioﬁlm former, 40
isolates were weak, 82 isolates were moderate, and 33 isolates
were strong producers of bioﬁlms (Table 2). Of the 104 isolates
in the standard microtiter plate method with moderate to strong
Figure 4. Bioﬁlm formation on the inner surfaces of glass.
Tube 1: Non-adherent cell; Tube 2: Weakly adherent cell; Tube 3:
Moderately adherent cell; Tube 4: Strongly adherent cell.
Figure 3. Growth on CRA medium.
Black pigmentation is indicative of bioﬁlm forming phenotype.
Table 2
Percentage of bioﬁlm phenotype in the A. baumannii isolates as depicted
by test tubes and microtiter plate methods. n (%).
Test Isolates
None Weak Moderate High
Test tubes 25 (16.03) 55 (35.25) 51 (32.69) 25 (16.03)
Standard microtiter
plate method
3 (1.93) 49 (31.41) 91 (58.33) 13 (8.33)
Modiﬁed microtiter
plate method
1 (0.64) 40 (25.64) 82 (52.56) 33 (21.16)
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115 isolates in modiﬁed microtiter plate method with moderate
or strong bioﬁlm forming trait, 106 (94.23%) were MDR. All
isolates with bioﬁlm positive trait on the CRA were MDR and
amongst the 76 isolates in test tube method with moderate to
high power bioﬁlm formation, 72 (94.74%) were MDR.
4. Discussion
A. baumannii is an opportunistic pathogen and one of the
main causes of nosocomial infections during the past few de-
cades [18]. This bacterium, especially MDR and bioﬁlm
producing strains can cause serious infectious diseases in
hospitalized patients. Due to their widespread resistance to
antimicrobial drugs, treatment of such infections can be very
difﬁcult. This study aimed to determine the prevalence of
antibiotic resistance and bioﬁlm-producing strains of
A. baumannii isolated from clinical samples and examine the
relationship between antibiotic resistance and bioﬁlm formation
using phenotypic methods.
Amongst the six hundred and ﬁfty infected samples which
were received, 156 A. baumannii isolates were recovered. This
constituted 80% of the total bacterial isolates. A. lwofﬁi
comprised 13.8% of the isolates and the rest belonged to other
species of Acinetobacter. This result was in agreement with the
study carried out by Mostoﬁ and her colleagues in 2010–2011
[19]. They isolated 50 bacteria, 71% of which were
A. baumannii, followed by A. lwofﬁi (17.1%) and other
species (11.9%). Likewise, Constantiniu et al. reported that
from a total of 24 clinical isolates, 71% were A. baumannii
and 29% were A. lwofﬁi [18]. Acinetobacter infections usually
involve organ systems with high ﬂuid content (e.g., respiratory
tract, CSF, peritoneal ﬂuid, urinary tract). In this study, most
isolates were recovered from trachea (23%) followed by pus
(21%), urine (17%), burn (17%) and wound (10%). Maryam
and her colleagues [20] found out the most prevalent isolates
were in trachea (25%) followed by urine (19%). Mostoﬁ et al.
reported that amongst the A. baumannii cases investigated,
30% were from respiratory tract infections, 12% were from
pus and 8% were originated from urinary tract infections [19].
In the current research, all A. baumannii isolates contained
the blaOXA-51-like gene. This result was in agreement with
other researchers [3,20,21]. Results of the antibiotic susceptibility
tests were very close to recent similar studies in Iran including
Vafaei et al. and Maryam et al. [19,20]. Mostoﬁ et al. reported
that their A. baumannii clinical strains were resistant to
gentamicin (61%), cefepime (95%), ciproﬂoxacin (88%), and
imipenem (76%). However, A. baumannii has retained
susceptibility to polymyxin B despite resistance to other
antibacterial agents. Maryam and her colleagues indicated that
their A. baumannii isolates showed resistance to
sulfamethoxazole (90%), imipenem (92%), gentamicin (84%),
and tetracycline (89%). Mak et al. [22] claimed that polymyxin
B is the most effective drug in controlling this bacterium.
Recent studies showed an overall increasing trend of resis-
tance to antibiotics. Houang and his colleagues reported that their
isolates showed 43% resistance to imipenem which was in
accordance with our result [11]. Soroush et al. indicated that
40.6% (59/145) of their A. baumannii isolates were identiﬁed
as MDR [23]. This ﬁnding indicates that antimicrobial resistance
of A. baumannii in Iran has increased, which may very well
affect the antimicrobial resistance of this organism worldwide.
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The result showed that 10% of the bacteria were bioﬁlm producer
which was in agreement with other studies [10]. As stated by
Hassan and his colleagues, 49% of bacteria were able to form
bioﬁlm moderately or with high power and the rest lacked
power of bioﬁlm formation or produced weakly [12]. The
results of standard microtiter plate using a qualitative approach
is also almost in agreement with Kaleem's study. In his study,
63% of the bacteria produced bioﬁlm and the rest were not able
to do so [12]. Dheepa et al. studied bioﬁlm production and their
results showed that 60% of their 50 isolates produced bioﬁlm
[6]. Likewise, another study demonstrated 62% of the 51
isolates formed bioﬁlm [24]. As a conclusion, all of them are in
agreement with results of this current study. Dheepa et al. in
their study that was conducted in 2011 and on 50 isolates of
A. baumannii, stated that bioﬁlms assays were performed by
three methods: tube method, standard microtiter plate and
modiﬁed microtiter plate [6]. The percentages of bioﬁlm
formation obtained in our study were very close to those
reported by Dheepa et al. [6]. Abdi-Ali et al. reported on bio-
ﬁlm production using test tube and modiﬁed microtiter plate
methods [4]. They worked on 100 isolates of A. baumannii and
obtained the following results in the test tube method: 18% no
power, 42% as weakly, 18% as moderate and 22% as high
power. The results of modiﬁed microtiter plate method were as
follows: 25% without bioﬁlm formation, 41% as weak, 10% as
moderate and 18% as high power values. These results were
somewhat different from the values obtained in this study. This
may be due to the difference in the number of clinical isolates
from different sources [4]. What is common in all these studies
is the observed intrinsic ability of this bacterium to form
bioﬁlms [4,5,10]. Although bioﬁlm assays are not difﬁcult to
perform, accurate readings of the test tube results are somewhat
subjective. However, it should be noted that certain changes in
the tube test procedure may improve the interpretation of the
results. After reading the OD of the standard microtiter plates
by ELISA reader, if we add 160 mL of glacial acetic (33% v/v)
to each well and again read the absorption, in this case, a
qualitative study will be converted to a quantitative one. In
fact, the shift from qualitative to a quantitative microtiter plate
method can prove to be a more reliable assay. The modiﬁed
microtiter plate assay is a very sensitive, accurate, and
reproducible method and can be used as a reliable quantitative
assay to determine bioﬁlm formation. The addition of acetic
acid permits measurement of the attached bacteria both on the
bottom as well as on the inner walls of the wells. Only 160 mL
of 33% (v/v) glacial acetic acid was added per well. This will
help to evade interference with stained matter at the liquid–air
interface, which is not considered to be indicative of bioﬁlm
formation in the tube tests [4].
Analyses of the results of this study also indicate that there is
a signiﬁcant correlation between power of bioﬁlm formation and
antibiotic resistance; considering that, more than 90% of the
bacteria with the ability to form bioﬁlms were MDR. This result
is in accordance with Hassan et al. study [12]. However, we
noted that those with weak or no power of bioﬁlm formation
showed higher resistance to other antibiotic. This is also in
agreement with other studies [4,5,10]. This can be due to
different mechanisms that may cause resistance to antibiotics
[4,5]. Resistance patterns amongst hospital-acquired bacterial
pathogens are often different from country to country and also
within a single country over time [4].In conclusion, the results showed that most clinical isolates of
A. baumannii have the ability to produce bioﬁlms. This could
potentially increase colonization of antibiotic-resistant bacteria
in hospital environments. Increased hospital acquired infections
can result in increased morbidity and mortality. Thus, a
continuous monitoring of antibiotic susceptibility in
A. baumannii isolated from different clinical sources in every
region seems necessary. These studies can provide useful in-
formation for selection of appropriate antimicrobial chemo-
therapy as well as adopting a suitable method for prevention
control. The modiﬁed microtiter plate assay seems to be the most
reliable and appropriate technique for detection of bioﬁlm
formation.
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